## Management of Small Cell Lung Cancer (SCLC) **Key Point:** Small cell lung cancer is staged as limited-stage (LD-SCLC) or extensive-stage (ED-SCLC). In this patient, CT chest/abdomen is normal and MRI brain is negative — standard staging is already complete. The confirmed diagnosis with mediastinal nodal involvement but no distant metastases places this patient in **limited-stage SCLC**, for which the standard of care is **concurrent chemoradiotherapy**. However, since thoracic radiotherapy planning is pending, initiating **chemotherapy with cisplatin and etoposide** is the most appropriate immediate next step. ### Why Option A is Correct **High-Yield:** Once SCLC is diagnosed and standard staging (CT chest/abdomen + MRI brain) is complete and negative for distant metastases, treatment should not be delayed. Cisplatin + etoposide is the backbone of SCLC chemotherapy for both limited and extensive stage disease. In limited-stage SCLC, thoracic radiotherapy is added concurrently (ideally from cycle 1 or 2), but chemotherapy initiation is the immediate priority. **Clinical Pearl:** SCLC is a rapidly proliferating tumor with a doubling time of ~30 days. Delay in treatment initiation significantly worsens prognosis. Standard staging in SCLC per NCCN and Indian guidelines includes CT chest/abdomen/pelvis and MRI brain — both of which have already been performed here. ### Why Other Options Are Incorrect | Option | Reason Incorrect | |--------|-----------------| | B) Surgical resection | Surgery is contraindicated in SCLC with mediastinal nodal involvement; SCLC is a systemic disease at presentation in >95% of cases | | C) Palliative radiotherapy alone | Inappropriate as primary treatment; SCLC is chemosensitive and systemic therapy is mandatory | | D) PET-CT + lumbar puncture | PET-CT may upstage disease but is NOT mandatory before initiating treatment when standard staging is already complete. **Lumbar puncture is NOT a routine pre-treatment staging requirement** in SCLC — it is reserved for symptomatic patients with suspected leptomeningeal disease. Delaying treatment for LP is not evidence-based. | ### SCLC Treatment Summary | Stage | Treatment | |-------|-----------| | Limited-stage | Concurrent cisplatin/etoposide + thoracic RT → PCI if complete response | | Extensive-stage | Cisplatin/carboplatin + etoposide ± atezolizumab → PCI if complete response | **Warning:** The claim that LP is "mandatory" before treatment in limited-stage SCLC is **not supported** by Harrison's, NCCN guidelines, or standard Indian oncology practice. LP is performed only when leptomeningeal disease is clinically suspected. [cite: Harrison 21e Ch 111; NCCN Guidelines SCLC v2024; DeVita Cancer: Principles & Practice of Oncology, 11e]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.